V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005936 | 320007404 | 1.83 | 74 | Palliative (P) | 2017-08-29 | 2017-08-30 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 320022496 | IRINOTECAN + VINCRISTINE |
| 320005937 | 320004281 | 1.66 | 70 | Palliative (P) | 2018-08-11 | 2018-09-14 | CARBOPLATIN + RT | 02 | N | 320022553 | TOPOTECAN |
| 320005938 | 320004282 | 1.64 | 61.4 | Palliative (P) | 2016-06-19 | 2016-12-09 | BEVACIZUMAB + CARBO + PACLITAXEL | 01 | N | 320022561 | EMA |
| 320005939 | 320004282 | 1.73 | 55.3 | Disease modification (D) | 2015-12-11 | 2015-12-19 | Gemcitabine weekly | N | N | 320022561 | CARBOPLATIN + DOCETAXEL |
| 320005940 | 320004283 | 1.8 | 83.9 | Palliative (P) | 2016-03-23 | 2016-09-22 | STS Rhabdomyosarcoma RMS 2005 VA | 02 | N | 320022635 | CISPLATIN + GEMCITABINE |
| 320005941 | 320005966 | 1.65 | 75 | Adjuvant (A) | 2018-09-26 | 2018-10-02 | ECX | 02 | N | 320023262 | OLAPARIB |
| 320005942 | 320004284 | 0 | 79.9 | Palliative (P) | null | 2016-08-17 | Temozolomide 200mg/m2 | N | N | 320023308 | CARBO + FLUOROURACIL |
| 320005943 | 320004285 | 1.7 | 74.6 | Palliative (P) | 2017-09-04 | 2017-10-14 | CARBOPLATIN + RT | N | N | 320023381 | CISPLATIN + ETOPOSIDE |
| 320005944 | 320004285 | 1.87 | 81.6 | Adjuvant (A) | 2016-08-13 | 2016-12-17 | NIVOLUMAB | N | N | 320023381 | TEMOZOLOMIDE |
| 320005945 | 320005968 | 1.8 | null | Adjuvant (A) | null | 2017-11-03 | Pemetrexed | null | null | 320023410 | GEMCITABINE |
| 320005946 | 320005968 | 1.67 | 58.2 | Palliative (P) | 2018-09-03 | 2018-09-16 | Capecitabine + Cisplatin | 02 | N | 320023410 | VINORELBINE |
| 320005947 | 320004287 | 1.69 | 85 | Curative (C) | 2017-02-21 | 2017-03-04 | Enzalutamide | 02 | N | 320023822 | TCF |
| 320005948 | 320004288 | 1.77 | 76.9 | Curative (C) | 2017-03-28 | 2017-03-28 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 320023932 | CARBOPLATIN + ETOPOSIDE |
| 320005949 | 320004290 | 1.76 | 56.5 | Palliative (P) | 2014-08-07 | 2014-12-27 | Carbo F | N | N | 320024471 | CARBOPLATIN + ETOPOSIDE |
| 320005950 | 320004290 | 1.8 | 109.1 | Neo-adjuvant (N) | 2016-11-13 | 2016-11-19 | CISPLATIN + ETOPOSIDE | 02 | N | 320024471 | PCV |
| 320005951 | 320004291 | null | 141.7 | Palliative (P) | 2019-10-10 | 2019-10-10 | IMATINIB | N | N | 320024715 | AFLIBERCEPT + FU + IRINOTECAN |
| 320005952 | 320005971 | 1.87 | 72 | Palliative (P) | 2016-01-03 | 2016-01-07 | PEMBROLIZUMAB | N | N | 320024806 | CETUXIMAB + CISPLATIN + FU |
| 320005953 | 320005971 | null | null | Adjuvant (A) | 2018-02-01 | 2018-03-15 | VAI (Ifos 3g/m2) | N | N | 320024806 | OCTOPUS TRIAL |
| 320005954 | 320004292 | 1.81 | 67.6 | Palliative (P) | 2017-06-03 | 2017-06-30 | CAPECITABINE + CARBOPLATIN + Cetuximab | null | null | 320025110 | DOCETAXEL |
| 320005955 | 320004292 | 1.62 | 51 | Adjuvant (A) | 2015-07-04 | 2015-07-10 | Trastuzumab Subcutaneous | 2 | N | 320025110 | CISPLATIN + GEMCITABINE |
| 320005956 | 320004292 | 1.6 | 87.6 | Palliative (P) | 2017-04-14 | 2017-04-28 | IPILIMUMAB + NIVOLUMAB | 01 | N | 320025110 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 320005957 | 320004293 | 1.73 | 81.2 | Palliative (P) | 2015-12-14 | 2015-12-20 | Cisplatin + Etoposide (3 day) | 02 | N | 320004242 | CARBOPLATIN + RT |
| 320005958 | 320004294 | 1.86 | 67.3 | Curative (C) | 2018-03-23 | 2018-03-30 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 320004814 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 320005959 | 320006771 | 1.6 | 71.3 | null | 2016-11-04 | 2017-11-14 | Capecitabine + Oxaliplatin 21day | N | N | 320005218 | DOCETAXEL |
| 320005960 | 320004295 | 1.1 | 53 | Neo-adjuvant (N) | 2016-09-08 | 2017-02-09 | POUT TRIAL | N | N | 320007575 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005961 | 320004298 | 1.63 | 81 | Palliative (P) | 2017-09-11 | 2017-09-15 | DOXORUBICIN | 1 | N | 320008094 | PEMBROLIZUMAB |
| 320005962 | 320005975 | null | 45.5 | null | null | 2018-04-24 | Rituximab | N | N | 320008329 | VAI |
| 320005963 | 320004303 | 1.6 | 70.4 | null | 2019-02-08 | 2019-02-18 | IVADo | N | N | 320008581 | IMATINIB |
| 320005964 | 320004308 | 1.65 | 93.8 | Palliative (P) | 2016-11-21 | 2016-12-18 | Cisplatin + Vinorelbine (IV) | N | N | 320009033 | PAC-E |
| 320005965 | 320004309 | 1.84 | 59.2 | Palliative (P) | 2014-07-15 | 2014-08-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320009033 | PEMBROLIZUMAB |
| 320005966 | 320004309 | 1.7 | 64.1 | Palliative (P) | 2019-05-01 | 2019-05-05 | CAPECITABINE + CETUXIMAB + CISPLATIN | Y | N | 320009033 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005967 | 320004310 | 1.62 | 66.9 | null | null | 2016-05-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320009881 | TEMOZOLOMIDE |
| 320005968 | 320004311 | 1.7 | 20.3 | Palliative (P) | 2018-08-08 | 2018-08-08 | Temozolomide 200mg/m2 | 02 | N | 320010225 | OLAPARIB |
| 320005969 | 320004313 | 1.68 | 57.2 | Curative (C) | 2018-04-20 | 2018-05-20 | CNS Low Grade Glioma Vinblastine | 02 | N | 320010225 | BORTEZOMIB |
| 320005970 | 320004314 | 1.59 | 87 | Palliative (P) | 2016-06-24 | 2016-06-24 | NIVOLUMAB | N | N | 320011851 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 320005971 | 320004315 | null | 55.9 | Palliative (P) | 2014-12-27 | 2014-12-27 | Niraparib | N | N | 320011983 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320005972 | 320004316 | 1.65 | 60 | Palliative (P) | 2018-03-09 | 2018-04-13 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 320012126 | IPILIMUMAB |
| 320005973 | 320004318 | null | 13.7 | Palliative (P) | 2019-04-08 | 2019-04-13 | CNS Low Grade Glioma Vinblastine | N | N | 320013061 | CARBOPLATIN + RT |
| 320005974 | 320005983 | null | 55.7 | Palliative (P) | null | 2014-07-07 | Carbo F | N | Y | 320016611 | RMS 2005 TRIAL |
| 320005975 | 320004320 | 1.67 | 71.7 | Palliative (P) | 2017-11-09 | 2017-11-23 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 320016712 | CARBOPLATIN + RT |
| 320005976 | 320004321 | 1.55 | 66 | Curative (C) | null | 2018-09-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | 320019033 | BEVACIZUMAB + CARBO |
| 320005977 | 320004322 | 1.62 | 70.4 | Palliative (P) | 2018-07-09 | 2018-07-23 | Capecitabine | N | N | 320021340 | CETUXIMAB + RT |
| 320005978 | 320004324 | 1.78 | 81.2 | Neo-adjuvant (N) | 2017-02-01 | 2017-06-03 | CAP | N | N | 320021501 | CARBO + FLUOROURACIL |
| 320005979 | 320004326 | 1.72 | 72 | Palliative (P) | 2019-11-04 | 2019-11-04 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 320021501 | DOCETAXEL |
| 320005980 | 320004328 | null | 59.6 | Adjuvant (A) | 2018-08-27 | 2018-10-06 | GEMCITABINE + TIP | N | null | 320022400 | CISPLATIN + PACLITAXEL |
| 320005981 | 320004328 | 1.57 | 70 | Palliative (P) | 2017-06-08 | 2017-06-18 | TRASTUZUMAB | 2 | N | 320022400 | CARBOPLATIN + ETOPOSIDE |
| 320005982 | 320004328 | 1.72 | 70.7 | null | null | 2017-10-18 | FLUOROURACIL + MITOMYCIN | 01 | N | 320022400 | CAPECITABINE + CISPLATIN |
| 320005983 | 320004329 | 1.76 | null | Palliative (P) | 2019-06-19 | 2019-07-25 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 320025365 | TCF |
| 320005984 | 320004329 | 1.79 | 94.6 | Palliative (P) | 2018-12-18 | 2019-01-02 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 320025365 | CARBOPLATIN + CETUXIMAB + FU |
| 320005985 | 320004330 | 1.67 | 55.6 | Palliative (P) | 2019-03-05 | 2019-04-24 | CISPLATIN + CYCLO + DOXORUBICIN | 02 | N | 320019431 | CAV |